Numinus Wellness Inc.

Good afternoon and welcome to Numinous Wellness Inc's fiscal first quarter 2023 results conference call. A question and answer session for analysts and institutional investors will follow the formal remarks. As a reminder, this call is being recorded. I would now like to turn the conference call over to your host, Jamie Kokoska, Vice President, Investor Relations. Please proceed.

Thank you, Emma. Good afternoon, everyone, and thank you for joining us for our fiscal first quarter 2023 results conference call. Discussing your minutes of performance today are Peyton Nyquist, founder and CEO, and John Fong, chief financial officer. Joining them for analyst questions at the end of our formal remarks are Reeve Robinson, chief clinical officer, and Paul Thiel-King, chief science officer. The following discussion may include forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties. The recent uncertainties that could cause our actual financial and operating results differ significantly from our forward-looking statements are detailed in our MDMA for the quarter, and in November 30, 2022, and in our other Canadian securities filings available on CDAR. NUMINIS does not undertake, update, or revise any forward-looking statements to reflect new events or circumstances, except as required by law. Our first quarter results were made available earlier this afternoon. We encourage you to review our earnings release, MD&A, and financial statements, which are available on our website as well as on CDAR. As a reminder, all figures discussed on today's call are in Canadian dollars.

I'll now turn the call over to Payton Nyquist, Chief Executive Officer. Thanks, Jamie, and good afternoon, everybody.